23andMe Holding Co (ME)
0.5452
-0.01
(-2.33%)
USD |
NASDAQ |
May 31, 16:00
0.5452
0.00 (0.00%)
After-Hours: 20:00
23andMe Gross Profit (Quarterly): 27.03M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 27.03M |
December 31, 2023 | 19.94M |
September 30, 2023 | 21.73M |
June 30, 2023 | 30.68M |
March 31, 2023 | 39.98M |
December 31, 2022 | 30.75M |
September 30, 2022 | 38.27M |
June 30, 2022 | 25.49M |
Date | Value |
---|---|
March 31, 2022 | 47.06M |
December 31, 2021 | 27.26M |
September 30, 2021 | 27.93M |
June 30, 2021 | 30.70M |
March 31, 2021 | 44.53M |
December 31, 2020 | 25.39M |
September 30, 2020 | 24.60M |
June 30, 2020 | 22.49M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
19.94M
Minimum
Dec 2023
47.06M
Maximum
Mar 2022
30.24M
Average
27.60M
Median
Gross Profit (Quarterly) Benchmarks
RadNet Inc | 44.12M |
DermTech Inc | 0.713M |
iSpecimen Inc | 1.29M |
Sera Prognostics Inc | -0.017M |
Progyny Inc | 62.41M |